SharesGrow.com Intrinsic Value of S&P & Nasdaq Contact Us

हिन्दी

← Back to all stocks

Mirati Therapeutics, Inc. MRTX NASDAQ

NASDAQ Global Select • Healthcare • Biotechnology • US • USD

SharesGrow Score

SharesGrow Intrinsic Value

Negative cash flow

Analyst Price Target

Mirati Therapeutics, Inc. (MRTX) has 12 identified peers for comparison in the Healthcare sector. Peers include AKRO, AMLX, APLS, DAWN, HEPA, ICPT and others.

MRTX has a market capitalization of $4.12B, compared to an average peer market cap of $4.48B.

Peers & Similar Companies — MRTX

Akero Therapeutics, Inc.

$54.65 0.00% $4.5B

Amylyx Pharmaceuticals, Inc.

$16.92 +2.73% $1.41B

Apellis Pharmaceuticals, Inc.

$40.85 +0.02% $5.22B

Day One Biopharmaceuticals, Inc.

$21.46 -0.14% $2.22B

Hepion Pharmaceuticals, Inc.

$0.05 +18.52% $557.78K

Intercept Pharmaceuticals, Inc.

$19.00 +0.21% $794.69M

Krystal Biotech, Inc.

$270.00 +0.97% $7.89B

Madrigal Pharmaceuticals, Inc.

$524.99 -0.13% $12.04B

PTC Therapeutics, Inc.

$73.01 +3.68% $6.04B

Reata Pharmaceuticals, Inc.

$172.36 +0.02% $6.57B

Sarepta Therapeutics, Inc.

$22.15 +1.65% $2.33B

Terns Pharmaceuticals, Inc.

$52.68 +0.13% $4.75B

People Also View

Madrigal Pharmaceuticals, Inc.

Krystal Biotech, Inc.

Reata Pharmaceuticals, Inc.

PTC Therapeutics, Inc.

Apellis Pharmaceuticals, Inc.

Terns Pharmaceuticals, Inc.

Akero Therapeutics, Inc.

Viking Therapeutics, Inc.

Contact Us

🎓

SharesGrow Academy

Learn how to calculate Intrinsic Value and find undervalued stocks.

Weekly live sessions

📧 [email protected]

📞 +65 8912 8000

Send us a message